Follow the people · Insider
Richard Nolan Townsend
Richard Nolan Townsend files insider transactions with the SEC as a chief executive officer of Lexeo Therapeutics (LXEO). We hold 5 disclosed purchases and sales filed since 9 January 2024, 2 of them in the last 90 days.
- Files forLXEO
- Disclosed buys and sells5 in all, 2 in the last 90 days
- Last disclosure19 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 5 January 2024 — 18 August 2026Chief Executive Officer · Lexeo Therapeutics (LXEO)55 Form 4 lines · source: SEC Form 4
Everything they disclosed
55 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 3,345 shares of Lexeo TherapeuticsSEC Form 419 August 2026Common Stock · traded 18 August 2026 · filed 19 August 2026
- was granted 67,000 shares of Lexeo TherapeuticsSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 25,947 shares of Lexeo TherapeuticsSEC Form 41 July 2026Common Stock · traded 1 July 2026 · filed 1 July 2026
- ▼ sold on the open market 3,342 shares of Lexeo TherapeuticsSEC Form 420 May 2026Common Stock · traded 18 May 2026 · filed 20 May 2026
- ▼ sold on the open market 55,000 shares of Lexeo TherapeuticsSEC Form 47 April 2026Common Stock · traded 6 April 2026 · filed 7 April 2026
- was granted 2,623 shares of Lexeo TherapeuticsSEC Form 417 March 2026Common Stock · traded 13 March 2026 · filed 17 March 2026
- was granted 2,623 shares of Lexeo TherapeuticsSEC Form 417 March 2026Common Stock · traded 13 March 2026 · filed 17 March 2026
- ▼ sold on the open market 10,173 shares of Lexeo TherapeuticsSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- ▼ sold on the open market 10,173 shares of Lexeo TherapeuticsSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- was granted 161,665 shares of Lexeo TherapeuticsSEC Form 46 February 2026Common Stock · traded 4 February 2026 · filed 6 February 2026
- was granted 646,665 shares of Lexeo Therapeutics (a derivative holding)SEC Form 46 February 2026Stock Option (right to buy) · traded 4 February 2026 · filed 6 February 2026
- was granted 646,665 shares of Lexeo Therapeutics (a derivative holding)SEC Form 46 February 2026Stock Option (right to buy) · traded 4 February 2026 · filed 6 February 2026
- was granted 161,665 shares of Lexeo TherapeuticsSEC Form 46 February 2026Common Stock · traded 4 February 2026 · filed 6 February 2026
- ▼ sold on the open market 1,127 shares of Lexeo TherapeuticsSEC Form 420 November 2025Common Stock · traded 18 November 2025 · filed 20 November 2025
- was granted 33,000 shares of Lexeo TherapeuticsSEC Form 417 October 2025Common Stock · traded 15 October 2025 · filed 17 October 2025
- ▼ sold on the open market 12,985 shares of Lexeo TherapeuticsSEC Form 417 October 2025Common Stock · traded 17 October 2025 · filed 17 October 2025
- ▼ sold on the open market 148 shares of Lexeo TherapeuticsSEC Form 417 October 2025Common Stock · traded 17 October 2025 · filed 17 October 2025
- was granted 2,193 shares of Lexeo TherapeuticsSEC Form 416 September 2025Common Stock · traded 12 September 2025 · filed 16 September 2025
- ▼ sold on the open market 1,115 shares of Lexeo TherapeuticsSEC Form 410 September 2025Common Stock · traded 18 August 2025 · filed 10 September 2025
- ▼ sold on the open market 2,735 shares of Lexeo TherapeuticsSEC Form 420 August 2025Common Stock · traded 18 August 2025 · filed 20 August 2025
- ▼ sold on the open market 1,074 shares of Lexeo TherapeuticsSEC Form 420 May 2025Common Stock · traded 16 May 2025 · filed 20 May 2025
- was granted 2,128 shares of Lexeo TherapeuticsSEC Form 41 April 2025Common Stock · traded 14 March 2025 · filed 1 April 2025
- ▼ sold on the open market 4,326 shares of Lexeo TherapeuticsSEC Form 421 February 2025Common Stock · traded 19 February 2025 · filed 21 February 2025
- was granted 207,500 shares of Lexeo Therapeutics (a derivative holding)SEC Form 410 January 2025Stock Option (right to buy) · traded 7 January 2025 · filed 10 January 2025
- was granted 103,750 shares of Lexeo TherapeuticsSEC Form 410 January 2025Common Stock · traded 7 January 2025 · filed 10 January 2025
- exercised options over 2,500 shares of Lexeo Therapeutics (a derivative holding)SEC Form 412 December 2024Stock Option (right to buy) · traded 10 December 2024 · filed 12 December 2024
- exercised options over 2,500 shares of Lexeo TherapeuticsSEC Form 412 December 2024Common Stock · traded 10 December 2024 · filed 12 December 2024
- ▼ sold on the open market 2,500 shares of Lexeo TherapeuticsSEC Form 412 December 2024Common Stock · traded 10 December 2024 · filed 12 December 2024
- exercised options over 2,500 shares of Lexeo Therapeutics (a derivative holding)SEC Form 413 November 2024Stock Option (right to buy) · traded 11 November 2024 · filed 13 November 2024
- exercised options over 2,500 shares of Lexeo TherapeuticsSEC Form 413 November 2024Common Stock · traded 11 November 2024 · filed 13 November 2024
- ▼ sold on the open market 2,500 shares of Lexeo TherapeuticsSEC Form 413 November 2024Common Stock · traded 11 November 2024 · filed 13 November 2024
- exercised options over 5,000 shares of Lexeo Therapeutics (a derivative holding)SEC Form 415 October 2024Stock Option (right to buy) · traded 10 October 2024 · filed 15 October 2024
- exercised options over 5,000 shares of Lexeo TherapeuticsSEC Form 415 October 2024Common Stock · traded 10 October 2024 · filed 15 October 2024
- ▼ sold on the open market 5,000 shares of Lexeo TherapeuticsSEC Form 415 October 2024Common Stock · traded 10 October 2024 · filed 15 October 2024
- exercised options over 5,000 shares of Lexeo Therapeutics (a derivative holding)SEC Form 411 September 2024Stock Option (right to buy) · traded 10 September 2024 · filed 11 September 2024
- exercised options over 5,000 shares of Lexeo TherapeuticsSEC Form 411 September 2024Common Stock · traded 10 September 2024 · filed 11 September 2024
- ▼ sold on the open market 5,000 shares of Lexeo TherapeuticsSEC Form 411 September 2024Common Stock · traded 10 September 2024 · filed 11 September 2024
- exercised options over 5,000 shares of Lexeo Therapeutics (a derivative holding)SEC Form 413 August 2024Stock Option (right to buy) · traded 12 August 2024 · filed 13 August 2024
- exercised options over 5,000 shares of Lexeo TherapeuticsSEC Form 413 August 2024Common Stock · traded 12 August 2024 · filed 13 August 2024
- ▼ sold on the open market 5,000 shares of Lexeo TherapeuticsSEC Form 413 August 2024Common Stock · traded 12 August 2024 · filed 13 August 2024
- exercised options over 5,000 shares of Lexeo Therapeutics (a derivative holding)SEC Form 412 July 2024Stock Option (right to buy) · traded 10 July 2024 · filed 12 July 2024
- exercised options over 5,000 shares of Lexeo TherapeuticsSEC Form 412 July 2024Common Stock · traded 10 July 2024 · filed 12 July 2024
- ▼ sold on the open market 23,622 shares of Lexeo TherapeuticsSEC Form 412 July 2024Common Stock · traded 10 July 2024 · filed 12 July 2024
- ▼ sold on the open market 3,347 shares of Lexeo TherapeuticsSEC Form 412 July 2024Common Stock · traded 10 July 2024 · filed 12 July 2024
- ▼ sold on the open market 27,931 shares of Lexeo TherapeuticsSEC Form 412 July 2024Common Stock · traded 11 July 2024 · filed 12 July 2024
- ▼ sold on the open market 100 shares of Lexeo TherapeuticsSEC Form 412 July 2024Common Stock · traded 11 July 2024 · filed 12 July 2024
- exercised options over 5,000 shares of Lexeo Therapeutics (a derivative holding)SEC Form 412 June 2024Stock Option (right to buy) · traded 10 June 2024 · filed 12 June 2024
- exercised options over 5,000 shares of Lexeo TherapeuticsSEC Form 412 June 2024Common Stock · traded 10 June 2024 · filed 12 June 2024
- ▼ sold on the open market 2,962 shares of Lexeo TherapeuticsSEC Form 412 June 2024Common Stock · traded 10 June 2024 · filed 12 June 2024
- ▼ sold on the open market 2,038 shares of Lexeo TherapeuticsSEC Form 412 June 2024Common Stock · traded 10 June 2024 · filed 12 June 2024
- exercised options over 5,000 shares of Lexeo Therapeutics (a derivative holding)SEC Form 414 May 2024Stock Option (Right to Buy) · traded 13 May 2024 · filed 14 May 2024
- exercised options over 5,000 shares of Lexeo TherapeuticsSEC Form 414 May 2024Common Stock · traded 13 May 2024 · filed 14 May 2024
- ▼ sold on the open market 5,000 shares of Lexeo TherapeuticsSEC Form 414 May 2024Common Stock · traded 13 May 2024 · filed 14 May 2024
- was granted 262,500 shares of Lexeo Therapeutics (a derivative holding)SEC Form 49 January 2024Stock Option (Right to Buy) · traded 5 January 2024 · filed 9 January 2024
- was granted 43,750 shares of Lexeo TherapeuticsSEC Form 49 January 2024Common Stock · traded 5 January 2024 · filed 9 January 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.